The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection.
Daniel J WardSanne GørtzMartin Thomsen ErnstNynne Nyboe AndersenSusanne K KjaerNina Sahlertz KristiansenSteffen ChristensenChristian Fynbo ChristiansenSimone Bastrup IsraelsenThomas Lars BenfieldJesper HallasTine JessPublished in: The European respiratory journal (2021)
Exposure to glucocorticoids was associated with increased risks of hospital admission and death. Further investigation is needed to determine the optimal management of COVID-19 in patients with pre-morbid glucocorticoid usage, specifically whether these patients require altered doses of glucocorticoids.